For decades, metabolic dysfunction-associated steatohepatitis (MASH), the more severe inflammatory form of fatty liver disease, was a silent epidemic, often…
Read More
ADA Conference Concludes with Groundbreaking GLP-1 Trial Results Amidst Unprecedented Protests Over Science Policy
The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read MoreHow CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford to Combat Bundibugyo Outbreak
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the urgent fast-tracking of three investigational vaccine candidates aimed at combating…
Read More
Pharmaceutical R&D Returns Soar to 7% Driven by GLP-1 Blockbusters, Raising Sustainability Questions for the Industry
After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…
Read More
Canada Makes History as First G7 Nation to Approve Generic Semaglutide, Sparking Global Debate on Patent Enforcement and Drug Access
In a landmark decision poised to reshape the landscape of diabetes and obesity management, Health Canada has granted authorization to…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector, a critical engine of medical innovation, is experiencing a robust resurgence, marking a significant turnaround from recent…
Read More
BD and Wellstar Connect Pharmacy-to-Bedside Medication Management with AI
BD (Becton, Dickinson and Company), a global leader in medical technology, has announced a landmark strategic partnership with Wellstar Health…
Read More
FDA Commissioner Marty Makary Resigns Amid Pressure from Administration, Citing Policy Conflicts and Agency Instability
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, amidst a period of intense…
Read MoreYOU MAY HAVE MISSED
